T0	Participants 657 753	patients undergoing standard versus extended lymphadenectomy in radical PD for pancreatic cancer
T1	Participants 768 947	March 2000 to May 2003, 112 patients with potentially curable pancreatic head cancer were enrolled and intraoperatively randomized to a standard or extended lymphadenectomy group.
T2	Participants 1011 1061	A hundred and one eligible patients were analyzed.
T3	Participants 1062 1143	Demographic and histopathological characteristics of the two groups were similar.
T4	Participants 1470 1517	patients with resectable pancreatic head cancer